Stockreport

Shares of Immunomedics rise 1% on FDA approval of breast-cancer drug [MarketWatch]

IMMUNOMEDICS  (IMMU) 
Last immunomedics earnings: 2/27 04:00 pm Check Earnings Report
PDF Shares of Immunomedics Inc. gained 1% in trading on Wednesday after the Food and Drug Adminstration (FDA) approved Trodelvy, the company's breast-cancer treatment. The d [Read more]